Book Review: Transhumanist Dreams and Dystopian Nightmares
By John Galloway,
BioNews
| 03. 11. 2013
Perhaps fortuitously, I started to read
Maxwell Mehlman's
book at the same time as
Roy Porter's 'A Short History of Madness'. It was then difficult not to muse on what
Jonathan Swift might have made of 'transhumanising scientists'. His satirising of scientists 'infected with lunacy' in the eighteenth century provides a hard to avoid parallel with Mehlman's very much not satirical account of biologists of the twentieth century.
Every school child now knows that molecular genetics is set to transform the world as we know it. Although exactly who 'we' are, is not specified; nor are we always told whether the transformation will be for good or ill. We can be reasonably certain though that most of the world's existing population will be dead before genetics' claims for medicine have any effect on them.
Read more...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...